英特集团：关于子公司英特药业收购华通医药股权的进展公告

Core Points - The company announced its decision to participate in the auction for 100% equity of Zhejiang Huato Pharmaceutical Group Co., Ltd. [2] - The company successfully acquired the 100% equity of Huato Pharmaceutical for a price of 369.10 million yuan [2] - The company received a non-prohibition decision from the State Administration for Market Regulation regarding the acquisition [2]